TUCSON
520.748.4400
About Us
Professional Staff
Board of Directors
Careers
Contact Us
Frederick Gardner
Cottrell Foundation
Successes
Ventures
Biotechnology
Medical Devices
Other
Historic Investments
Technologies
The CH2 Domain Scaffold – ABDURINS™
Deimmunized Sarcin Ribotoxin
Endotoxin-free ClearColi™ Expression System
Fibronectin Artificial Antibody Scaffold
Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)
Pichia Classic Expression Platform
Pichia GlyoSwitch™ Protein Expression System
Shingles Vaccine Antigen
Ultrasound Tissue Harmonic Imaging
VIMPAT® (lacosamide) for Treatment of Epileptic Seizures
Innovate With Us
News & Events
Home
»
News & Events
»
2013
RCT Ventures Announces FLI Medical Innovations Wins the MedTech Idol Qualifying Round at IN3 Summit
10.25.2013
Jenrin Discovery Announces Recent Advances in Understanding of the Endocannabinoid System Using JD-5037
9.11.2013
RCT Ventures Announces 2013 MedTech Idol: LIM Innovations
6.28.2013
RCT and BioGrammatics Announce Partnership, Launch of the Pichia pastoris GlycoSwitch® Expression System
6.4.2013
Lucigen and RCT Announce Partnership and Launch Endotoxin-free CleanColi™ Expression System
5.1.2013
Antitope Ltd. and RCT Announce Protein Deimmunisation Research Agreement
4.22.2013
Alcon and ThromboGenics Announce EU Approval of Pichia-manufactured Jetrea®
3.18.2013
Vimpat® (Lacosamide) Generates Positive Results in U.S. Phase 3 Monotherapy Study
3.5.2013
News by Year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
From concept
to market
Innovate with us ›